Загрузка...
Proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia: case review
Proton pump inhibitor (PPI)-induced hypomagnesaemia is a rare but serious adverse effect of a widely prescribed medication. It has become an increasingly recognised complication since 2006, with the U.S. Food and Drug Administration issuing a warning for this risk with regards to long-term PPI use....
Сохранить в:
| Опубликовано в: : | Int J Physiol Pathophysiol Pharmacol |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
e-Century Publishing Corporation
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5209446/ https://ncbi.nlm.nih.gov/pubmed/28078056 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|